Streetbeat News

Products Services

NVAX

Novavax Inc (NASDAQ:NVAX) received European marketing authorization for its updated Nuvaxovid COVID-19 vaccine targeting the JN.1 variant. The vaccine is authorized for emergency use in the U.S. but not fully approved by the FDA. NVAX shares initially rose but then fell slightly.

Portfolio Pulse from Adam Eckert

October 09, 2024 | 2:43 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides a detailed analysis of key stocks and ETFs, including SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. It highlights potential price levels and trading strategies for these assets, emphasizing the importance of monitoring market dynamics and adjusting tactics accordingly. The memo also notes upcoming economic events that could impact market volatility.

Portfolio Pulse from RIPS

October 09, 2024 | 2:37 pm

BAC

COST

This week's investment news highlights include Bank of America's system outage, Japan's monetary policy challenges, Costco's expansion into platinum sales, rising oil prices due to Middle East tensions, and strategies for handling stock losses. Bank of America faced a significant outage, causing customer panic, while Japan's decision to maintain low interest rates led to a yen decline. Costco is now selling platinum bars, reflecting increased demand for precious metals. Global tensions are driving oil prices up, complicating the Federal Reserve's recent rate cut. Investors are advised to consider diversification and strategic stock management.

Portfolio Pulse from Gary Brode

October 09, 2024 | 2:34 pm

SOLUSD

Bitget Research predicts Solana (SOL) could reach $160-$180 in October, driven by memecoin activity and strong ecosystem support. Solana's stability and partnerships with Franklin Templeton and Citibank enhance its appeal. The memecoin boom is expected to continue, with Bitget emphasizing community-driven tokens.

Portfolio Pulse from Justin Roberti

October 09, 2024 | 2:31 pm

CRLBF

MSOS

Cresco Labs CEO Charlie Bachtell emphasizes the importance of scale and efficiency in the cannabis industry, highlighting the capital-intensive nature of building and operating businesses. Cresco Labs has developed a leading market position with its 'House of Brands'.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:26 pm

CRLBF

MSOS

Cresco Labs CEO Charlie Bachtell emphasizes the importance of being capital efficient, tight, and self-sufficient to succeed in the current cannabis market. This approach is crucial for taking advantage of future opportunities.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:23 pm

CLSD

Clearside Biomedical's investigational drug CLS-AX for wet AMD achieved primary and secondary goals in a Phase 2b trial, showing stable visual acuity and anatomy with a well-tolerated safety profile. The trial results support the design of a planned Phase 3 program.

Portfolio Pulse from Vandana Singh

October 09, 2024 | 2:22 pm

CRLBF

MSOS

Cresco Labs CEO Charlie Bachtell emphasized the company's focus on preparing for significant opportunities in 2024, particularly in states like Ohio, Florida, and Pennsylvania, which are moving towards adult-use cannabis legalization.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:22 pm

NIO

NIO Inc's stock has dropped 10% this week due to volatility in Chinese stocks, driven by disappointment over the lack of aggressive fiscal stimulus from Beijing. The Hang Seng Index's significant drop has raised concerns about consumer demand for electric vehicles in China, a key market for NIO.

Portfolio Pulse from Henry Khederian

October 09, 2024 | 2:17 pm

TSLA

Tesla Inc (NASDAQ:TSLA) is in focus as it prepares for its robotaxi event, following record shipments in China. Despite strong deliveries, Tesla's Q3 total fell short of some expectations. Analysts anticipate significant updates at the event, which could drive future growth.

Portfolio Pulse from Adam Eckert

October 09, 2024 | 2:17 pm